Department of Intensive Care Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Department of Intensive Care Medicine, Amsterdam UMC, Amsterdam Medisch Centrum, Meibergdreef 9, Amsterdam, The Netherlands.
Crit Care. 2024 Sep 17;28(1):307. doi: 10.1186/s13054-024-05075-y.
We would like to extend our gratitude to Dr. da Hora Passos et al. for their interest in our recently published review and meta-analysis in Critical Care. In this response, we will elaborate on the points raised by the authors. We agree with the authors that LUS, like any other diagnostic technique, is valuable and safe only when utilized by trained operators. The authors expressed uncertainty regarding the sensitivity of LUS in detecting mild ARDS or ARDS at an early stage. This variance in sensitivity is more likely due to diversity in diagnostic thresholds. We advocate for global collaboration among LUS experts to align LUS methodologies and strengthen the evidence supporting LUS in the diagnosis of ARDS and its morphological subphenotypes.
我们要感谢 da Hora Passos 博士等作者对我们最近在《危重病医学》上发表的综述和荟萃分析的关注。在本次回复中,我们将详细阐述作者提出的观点。我们同意作者的观点,即像任何其他诊断技术一样,只有经过培训的操作人员使用时,超声才具有价值且安全。作者对超声检测轻度 ARDS 或早期 ARDS 的敏感性表示不确定。这种敏感性的差异可能更多是由于诊断阈值的多样性。我们主张超声专家之间进行全球合作,使超声方法学标准化,并加强支持超声诊断 ARDS 及其形态亚表型的证据。